RecruitingNCT07125885
Gongji Pregnancy Endorine Cohort Study
Serological, Metabolomic, and Genomic Studies of Endocrine Disorders in Pregnancy
Sponsor
Shanghai General Hospital, China
Enrollment
3,000 participants
Start Date
May 5, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To explore the relationship between genetic factors, lifestyle, and drug interventions and the occurrence, development, adverse pregnancy outcomes, and postpartum maternal-infant outcomes of gestational endocrine diseases.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years
Inclusion Criteria3
- Women preparing for pregnancy or pregnant women or within 1 year after giving birth
- Age ≥ 18 years old
- Signed the informed consent form to voluntarily enroll in the management follow-up
Exclusion Criteria3
- Individuals who are unable to communicate normally and those who are unwilling to cooperate
- Pregnant women with severe organic diseases or mental illnesses
- Any condition deemed by the investigator to affect eligibility for the study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07125885